Patent application number | Description | Published |
20090157355 | Method and device for diagnosing an ascertainment of a performance quantity of an internal combustion engine - A method and a device for diagnosing an ascertainment of a performance quantity of an internal combustion engine. Within the scope of a first diagnostic process a first value which is characteristic of a first performance quantity of the internal combustion engine ascertained at a first point in time after switching off the internal combustion engine is compared to a predefined value, and an error is identified when in the comparison it is detected that the absolute value of a first difference between the first value and the predefined value exceeds a predefined first threshold value for the first point in time. The predefined first threshold value is predefined to be smaller the longer the time since the internal combustion engine has been switched off. An identified error is cleared in a subsequent second diagnostic process when, for a second difference between the first value and the predefined value for a second point in time, it is detected within the scope of the subsequent second diagnostic process that the absolute value of the second difference does not exceed a second threshold value predefined for the second point in time. An error identified within the scope of the first diagnostic process is cleared within the scope of the subsequent second diagnostic process only when the predefined second threshold value does not exceed a predefined limiting value. The predefined limiting value is formed as a function of the predefined first threshold value. | 06-18-2009 |
20110106396 | METHOD AND CONTROLLER FOR CHECKING AN EXHAUST GAS AFTERTREATMENT SYSTEM OF AN INTERNAL COMBUSTION ENGINE - The invention relates to a method for checking the operability of an exhaust gas after-treatment system ( | 05-05-2011 |
20120191320 | METHOD FOR MONITORING THE ENABLING OF A SYSTEM - A method for monitoring the enabling of a system which is assigned to an internal combustion engine, in which the readiness for operation of the system is dependent on an operating temperature, is characterized in that a fault in the enabling of the system is inferred ( | 07-26-2012 |
20130097999 | METHOD FOR HEATING A CATALYTIC CONVERTER IN AN ENGINE SYSTEM AND FOR DIAGNOSING THE EFFECTIVENESS OF MEASURES FOR HEATING THE CATALYTIC CONVERTER - A method for operating an internal combustion engine in a catalytic converter heating operation, the internal combustion engine being able to be operated in a normal operation, including the following steps: ascertaining a first exhaust gas temperature reading, which gives the exhaust gas temperature of the exhaust gas in a first catalytic converter, particularly in an oxidation catalytic converter; operating the internal combustion engine in a first operating mode, in which, in contrast to the normal operation, the exhaust gas, having an increased exhaust gas temperature, is exhausted from at least one cylinder of the internal combustion engine, as long as the first exhaust gas temperature reading has not reached a specified first temperature threshold value. This method enables a robust and simple diagnosis of the effectiveness of the catalytic converter heating operation according to the requirements of CARE Title | 04-25-2013 |
Patent application number | Description | Published |
20130282381 | METHODS AND SYSTEMS FOR SPEECH-ENABLING A HUMAN-TO-MACHINE INTERFACE - Generally, human-to-machine interfaces are configured to accept speech input from a user. However, such interfaces, e.g., web browsers, must be configured to enable acceptance of speech input from the user. Some interfaces, such as mobile browsers, have less configuration adaptability and are not able to be configured to accept speech input from a user. Embodiments of the present invention speech-enable human-to-machine interfaces by loading content of the human-to-machine interface and adding logic configured to enable speech interaction with the content to the interface. The embodiment then activates speech interaction with the content via the logic for the user. Thus, embodiments of the present invention enable speech interaction with interfaces that are not configured to be adapted to allow speech interaction and are able to enable the speech interaction in a seamless manner. | 10-24-2013 |
20140253455 | TASK ASSISTANT PROVIDING CONTEXTUAL SUGGESTIONS - A method of providing a task assistant to provide an interface to an application is described. The method comprises, in one embodiment, providing a task assistant to provide an interface to an application, to receive input from a user through multimodal input including a plurality of speech input, typing input, and touch input. The method further comprises receiving a request from a user for a suggestion, determining a current transaction state, based on interactions with the user during a current session, and selecting suggestions relevant to a transaction type associated with the current transaction state. | 09-11-2014 |
20140258323 | TASK ASSISTANT - A method of providing a task assistant to provide an interface to an application is described. The method comprises receiving input from a user through multimodal input including a plurality of speech input, typing input, and touch input, interpreting the input, and providing a formatted query to the application, receiving data from the application in response to the query, and providing a response to the user through multimodal output including a plurality of: speech output, text output, non-speech audio output, haptic output, and visual non-text output. | 09-11-2014 |
20140258324 | TASK ASSISTANT UTILIZING CONTEXT FOR IMPROVED INTERACTION - A method of providing a task assistant is described. The task assistant is designed to receive input from a user through multimodal input including a plurality of speech input, typing input, and touch input, determine the meaning of the input, and determining whether there is a context based on prior interactions with the user. The method further to generate an interpreted input based on a combination of the input and the context, and providing a formatted query to an application. The method further to receive data from the application in response to the formatted query, and provide a response to the user through multimodal output including a plurality of: speech output, text output, non-speech audio output, haptic output, and visual non-text output. The method further to update the context based on the interpreted input. | 09-11-2014 |
20140258855 | TASK ASSISTANT INCLUDING IMPROVED NAVIGATION - A method of providing a task assistant to provide an interface to an application is described. The method includes, in one embodiment, receiving input from a user through multimodal input including a plurality of each input, typing input, and touch input, interpreting the input, and providing a formatted query to the application, and receiving data from the application in response to the query. The method further includes identifying a destination providing a response to the query, identifying an anchor pointing to a specific location in the application associated with the response to the query, and directing the user to the specific location, using the anchor, the specific location providing a response to the user. | 09-11-2014 |
20150162005 | METHODS AND SYSTEMS FOR SPEECH-ENABLING A HUMAN-TO-MACHINE INTERFACE - Generally, human-to-machine interfaces are configured to accept speech input from a user. However, such interfaces, e.g., web browsers, must be configured to enable acceptance of speech input from the user. Some interfaces, such as mobile browsers, have less configuration adaptability and are not able to be configured to accept speech input from a user. Embodiments of the present invention speech-enable human-to-machine interfaces by loading content of the human-to-machine interface and adding logic configured to enable speech interaction with the content to the interface. The embodiment then activates speech interaction with the content via the logic for the user. Thus, embodiments of the present invention enable speech interaction with interfaces that are not configured to be adapted to allow speech interaction and are able to enable the speech interaction in a seamless manner. | 06-11-2015 |
Patent application number | Description | Published |
20090197902 | Use of Pyrimidine Compounds in the Preparation of Parasiticides - The invention relates to the use of compounds of the general formula (I), wherein R | 08-06-2009 |
20100010003 | Pyrimidine Derivatives And Their Use As Pesticides - The invention relates to new pyrimidine compounds of formula (1) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (1) are useful in the control of parasites, in particular ectoparasites, in and on warmblooded animals. | 01-14-2010 |
20100063090 | Composition for Repelling and Deterring Vermin - The invention describes essentially a non-therapeutical process for deterring vermin, which is based on the usage of the largely known beta amino-alcohol derivatives of formula (I), as defined herein before. Furthermore, it describes the corresponding vermin-deterring compositions which contain these substances as the active ingredient, compounds of the formula (I) for the preparation of vermin-deterring compositions, and the use of compounds of formula (I) in the defense against vermin. Thus, the invention describes how and in which form the compounds of the formula (I) or their acid addition salts are used to deter vermin from materials, places or warm-blooded animals. | 03-11-2010 |
20100303865 | USE OF OXAZOLE DERIVATIVES FOR CONTROLLING FISH PARASITES - The present invention relates to the use of compounds of formula (I), wherein R | 12-02-2010 |
20110021543 | HETEROCYCLIC COMPOUNDS AND THEIR USE AS PESTICIDES - Novel N-aryl substituted heteroindole compounds, processes for their manufacture, veterinary compositions containing such compounds, and methods of controlling ectoparasites are provided. The compounds are believed effective in the control of ectoparasites on warm-blooded productive livestock and domestic animals. | 01-27-2011 |
20130143924 | COMPOSITION FOR REPELLING AND DETERRING VERMIN - The present invention is directed to a non-therapeutical process for deterring vermin, which is based on the usage of the largely known beta amino-alcohol derivatives of formula (I) | 06-06-2013 |
Patent application number | Description | Published |
20090123953 | Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same - An intramolecular bioluminescence resonance energy transfer (BRET), biosensor for monitoring receptor activity and signalling cascades is disclosed. The “double-brilliance” biosensor sandwiches β-arrestin (β-arr) between Renilla | 05-14-2009 |
20090298162 | BIOSENSORS FOR MONITORING RECEPTOR-MEDIATED G-PROTEIN ACTIVATION - The present invention relates to novel biosensors that are based on bioluminescence resonance energy transfer (BRET). These biosensors may be used to monitor rapid interaction and conformational changes within G protein-coupled receptor/G protein complexes and, in this way, reflect the activation status of the receptor. Advantageously, the biosensors may be used as a highly sensitive and quantitative assay for the identification of ligands (agonists, antagonists, inverse agonists, partial agonists, etc.) targeting G protein-coupled receptors (GPCRs) as well as for the analysis of the activation status of these receptors. Moreover, multiplexing different biosensors within receptors/G protein complexes allows for mapping ligand textures. Additionally, the biosensors permit the direct, real-time examination of interactions between receptors and G protein in their natural environment, the living cell. | 12-03-2009 |
20090312345 | PHARMACOLOGICAL CHAPERONES FOR TREATING OBESITY - The invention relates to methods of enhancing normal melanocortin-4 receptor (MC4R) activity, and to enhancing activity of an MC4R having a mutation which affects protein folding and/or processing of the MC4R. The invention provides a method of treating an individual having a condition in which increased activity of an MC4R at the cell surface would be beneficial, for example in obesity, by administering an effective amount of a pharmacological chaperone for the MC4R. The invention provides MC4R pharmacological chaperones which enhance the activity of MC4R. The invention further provides a method of screening to identify pharmacological chaperones which enhance folding of an MC4R in the endoplasmic reticulum (ER), in order to enhance the activity of the MC4R at the cell surface. | 12-17-2009 |
20110275134 | Arrestin Biosensor - The present invention relates to a novel biosensor. A resonance energy transfter (RET) biosensor comprising a beta(β)-arrestin tagged with a first and a second chromophore, wherein said first chromophore is a fluorophore and said second chromophore is a fluorophore or a bioluminophore is described. | 11-10-2011 |
20130165426 | IMIDAZOPYRIDINE, IMIDAZOPYRIMIDINE AND IMIDAZOPYRAZINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS - Disclosed is a compound of Formula I or a salt thereof, in which X, X1, X2, R1, R2, and R3 are described herein. Also disclosed are pharmaceutical compositions and methods of using the compounds of Formula I to treat disorders mediated by melanocortin-4 receptors. | 06-27-2013 |
20140057894 | PYRAZOLOPYRIDINE AND PYRAZOLOPYRIMIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS - Disclosed herein is a compound of Formula I: wherein X, R | 02-27-2014 |
20150150224 | TRANSGENIC MOUSE MODELS FOR MC4R - There are provided herein transgenic non-human animals and cells comprising a transgene encoding either a mutated human melanocortin type-4 receptor (hMC4R) protein, wherein the mutated protein is misfolded and retained intracellularly, or a wild-type human melanocortin type-4 receptor (hMC4R) protein. Transgenes and targeting constructs used to produce such transgenic animals and cells are also provided, as well as methods for using the transgenic animals in pharmaceutical screening and as commercial research animals for modeling obesity. | 06-04-2015 |
20150197520 | PYRAZOLOPYRIDINE AND PYRAZOLOPYRIMIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS - Disclosed herein is a compound of Formula I: | 07-16-2015 |